NEWSTrending Headlines Courtesy of Health Economics

Top Story

New $1000-a-Month Weight Loss Drug Debuts in US

Find out more about Novo Nordisk's recently released obesity therapy, Saxenda, here. The US is the first market for release, seeing a premium price tag of $1000/ month -expected by analysts, but significantly more than other recently launched obesity drugs. (Source: Phil Taylor, PMLiVE, 4/23/15)

Read More Bookmark and Share

Featured Stories


Stay Connected